The study of the effects of tDCS on gait and balance dysfunction on Parkinson’s patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0010917

Enrollment

Registered

2025-08-19

Start date

2025-02-13

Completion date

Unknown

Last updated

2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : The primary intervention is transcranial direct current stimulation . It is delivered as follows: regardless of lesion location, the anode is placed on the right mastoid and the catho

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Outpatients at our hospital who meet all of the following conditions and provide written informed consent. 2. Diagnosis of definite clinical Parkinson’s disease according to the UK Parkinson’s Disease Society Brain Bank criteria and currently taking antiparkinsonian medication. 3. Able to stand and walk unaided, permitting evaluation with the Foot Scan System, Timed Up and Go (TUG) test, and Berg Balance Scale (BBS). 4. Capable of understanding the study procedures, following instructions, and communicating effectively. 5. Willing to participate in the study and comply with follow-up assessments. 6. Aged between 50 and 80 years (inclusive). (For very elderly participants, if the research team judges that decision-making capacity may be limited, written consent will be obtained from both the participant and a legal representative.)

Exclusion criteria

Exclusion criteria: 1. Individuals who do not consent to participate in the study. 2. Patients with anatomical abnormalities detected on brain MRI or with previously identified central lesions capable of causing vertigo. 3. Individuals with a history of auditory or vestibular disorders, or with neurological or orthopedic conditions that compromise balance or gait. 4. Individuals currently taking antiepileptic medication or with a past history of seizures/epilepsy. 5. Individuals with pre-existing cognitive impairment or severe psychiatric disorders. 6. Women of childbearing age and pregnant women.

Design outcomes

Primary

Measure	Time frame
Improvement of gait and balance dysfunction	—

Secondary

Measure	Time frame
Hoehn & yahr stage and UPDRS partIII;functional MRI;Video-oculography	—

Countries

Korea, Republic of

Contacts

Public ContactSunyoung Oh

Jeonbuk National University

ohsun@jbnu.ac.kr+82-63-250-1590

Outcome results